STOCKHOLDERS' EQUITY - Narrative (Details) - USD ($) $ in Thousands |
3 Months Ended | |||
|---|---|---|---|---|
Mar. 31, 2025 |
Mar. 31, 2024 |
Dec. 31, 2024 |
Aug. 02, 2024 |
|
| Share-based Compensation Arrangement by Share-based Payment Award | ||||
| Stock-based compensation | $ 3,859 | $ 2,799 | ||
| Term Loan Agreement | ||||
| Share-based Compensation Arrangement by Share-based Payment Award | ||||
| Share repurchase program, authorized, amount | $ 250 | $ 5,000 | ||
| Restricted Stock | ||||
| Share-based Compensation Arrangement by Share-based Payment Award | ||||
| Unrecognized compensation expense | $ 30,468 | |||
| Unrecognized compensation expense, weighted average period of recognition (in years) | 2 years | |||
| Stock-based compensation | $ 3,859 | $ 2,799 | ||
| X | ||||||||||
- Definition Amount authorized for purchase of share under share repurchase plan. Includes, but is not limited to, repurchase of stock and unit of ownership. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of cost to be recognized for nonvested award under share-based payment arrangement. Excludes share and unit options. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of noncash expense for share-based payment arrangement. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|